Logo Logo
Help
Contact
Switch Language to German

Tamalunas, Alexander; Westhofen, Thilo; Schott, Melanie; Keller, Patrick; Atzler, Michael; Stief, Christian G. and Magistro, Giuseppe (2021): The impact of preoperative lower urinary tract symptoms medication on the functional performance of holmium laser enucleation of the prostate. In: Central European Journal of Urology, Vol. 74, No. 3: pp. 429-436

Full text not available from 'Open Access LMU'.

Abstract

Introduction Medical treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic ob-struction (BPO) targets prostate size, to prevent disease progression, and prostate smooth muscle tone for rapid relieve of LUTS. Holmium laser enucleation of the prostate (HoLEP) is a size-independent method for surgical treatment of LUTS/BPO in medication-refractory patients and offers durable long-term results with reduced perioperative morbidity. As up to 50% of patients receive medical treatment for LUTS/BPO prior to surgery, we analyzed the impact of alpha-blockers and 5-alpha reductase inhibitors (5-ARI) on outcomes and perioperative morbidity in patients undergoing HoLEP for LUTS. Material and methods We retrospectively gathered data of 1,057 patients, who underwent HoLEP for LUTS/BPO from 2013-2018, and divided patients into group 1 (no medication), group 2 (alpha-blockers), and group 3 (5-ARI and alpha-blockers). Perioperative parameters, short-term functional outcomes and safety were assessed and statistical analysis was performed using SPSS V26.0 software. Results Even though preoperative LUTS profile was significantly different between groups, all patients improved significantly after HoLEP, irrespective of preoperative LUTS medication. Median improvement of IPSS was 9, 8 and 7 points, of Q(max) was 10, 12 and 9.5 ml/s, with significant improvement of quality of life (QoL) and reduction of post-void residual volume (PVR) for groups 1-3, respectively, 30 days after surgery. With only 4.0% (42/1,057) of patients experiencing a Clavien-Dindo grade >= II complication, there was no difference in prevalence of perioperative complications between groups (p = 0.943). Conclusions Although preoperative LUTS medication does not impair efficacy of HoLEP with acceptable perioperative morbidity, the time gap between medical therapy and surgical treatment may favor an earlier response.

Actions (login required)

View Item View Item